Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Mechanistic rationale for MCL1 inhibition during androgen deprivation therapy.
Oncotarget. 2015 Mar 20;6(8):6105-22. doi: 10.18632/oncotarget.3368.
Oncotarget. 2015.
PMID: 25749045
Free PMC article.
Olaparib is effective in combination with, and as maintenance therapy after, first-line endocrine therapy in prostate cancer cells.
Feiersinger GE, Trattnig K, Leitner PD, Guggenberger F, Oberhuber A, Peer S, Hermann M, Skvortsova I, Vrbkova J, Bouchal J, Culig Z, Santer FR.
Feiersinger GE, et al.
Mol Oncol. 2018 Apr;12(4):561-576. doi: 10.1002/1878-0261.12185. Epub 2018 Mar 15.
Mol Oncol. 2018.
PMID: 29465803
Free PMC article.
Item in Clipboard
Cite
Cite